skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

NewAmsterdam Pharma Doses First Patient in PREVAIL, the Cardiovascular Outcomes Trial of Obicetrapib in Adults with Atherosclerotic Cardiovascular Disease (ASCVD)

Business Wire, 2022-03-01

COPYRIGHT 2022 Business Wire, Inc.

Digital Resources/Online E-Resources

Citations Cited by

Searching Remote Databases, Please Wait